Ledger.Open graph →
SEC Form D · filed February 17, 2021

Halia Therapeutics, Inc

Offering
$5.0M
Sold
$5.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SALT LAKE CITY, UT
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

John S. Kauwe · Salt Lake City, UTDirector · PromoterDavid Bearss · Salt Lake City, UTExec · Director · PromoterJared Bearss · Salt Lake City, UTExec · Director · PromoterPatrick Van Roten · Woodbury, NYExec · Director · PromoterLance S. Etcheverry · Dallas, TXDirector · PromoterJeffrey Filone · Woodbury, NYExec · Director · PromoterMike S. Mccullar · Salt Lake City, UTExec · DirectorJim S. Savas · Salt Lake City, UTDirectorWilliam Mcnichols · Seattle, WADirector · PromoterSean Collins · Seattle, WAExec · Director · PromoterKevin Colas · Dover, DEExec · Director · PromoterMike S. Mccullar · Salt Lake City, UTExec · DirectorJim S. Savas · Salt Lake City, UTDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗